AIM OF THE JoMO Medicines optimisation is a person-centred approach to safe and effective medicines use to ensure that people obtain the best possible outcomes from their medicines. The aim of the JoMO is to contribute to that process and play an influential and key part in shaping better patient care and the role that medicines can play. The JoMO provides a vehicle to enable healthcare professionals to stimulate ideas in colleagues and/or disseminate good practice that others can adapt or develop to suit their local circumstances. READERSHIP The JoMO is made available on a controlled circulation basis to healthcare professionals (e.g. pharmacists, doctors, nurses, etc) and industry colleagues who work with them. EDITORIAL STAFF The JoMO is supported with the staff shown at the end of the journal. CLINICAL EDITORIAL GROUP A range of experience covering various clinical specialties, organisations and disciplines is available to help steer the development of the JoMO and ensure that it provides a useful resource for readers. Details of membership of the group are shown at the end of the journal. PEER REVIEW/CLINICAL CONSULTANCY NETWORK The JOMO has a network of persons available to provide advice and undertake peer review of articles. Material that appears in full articless will have been subject to peer review. The emphasis in the JoMO is on disseminating best practice through good quality publications. The aim of the peer review process is to provide advice on the suitability of an article for publication as well constructive comment to assist authors, where appropriate, to develop their paper to a publishable standard. Peer review is conducted on a single blind basis and authors are not informed of the name(s) of Peer Reviewers. Peer Reviewers are required to declare any conflicts of interest they have regarding a particular manuscript and to exclude themselves from the peer review process if these could significantly complicate their review or inappropriately bias their opinion. Manuscripts are treated as confidential and it is a requirement that Peer Reviewers do not share or discuss it with colleagues. It is a requirement that Peer Reviewers should not use knowledge of the work they are reviewing before its publication to further their own interests. Peer Reviewers provide advice to the Editor-in-Chief. Where there is a significant variation of views at least one other Peer Reviewer may be contacted for advice before a final-decision is made regarding the outcome for the manuscript. The Editor-in-Chief is ultimately responsible for the selection of all content. COMMUNICATION CHANNELS A learned journal should open its pages to scholarly debate and we hope that readers will share their views and questions in the following ways. LINKEDIN Readers who use LinkedIn may like to know that there is a JOMO LinkedIn Group. It is a closed group but everyone who requests the JoMO will be permitted to join. Readers are encouraged to comment upon and discuss items about medicines optimisation. TWITTER Readers are encouraged to follow Pharmacy Management on @pharman to use our dedicated Twitter hashtag (#jmedopt) to draw attention to and debate topical issues having to do with medicines optimisation. CORRESPONDENCE Constructive comment to further understanding and debate about a topic is encouraged and welcomed. Any competing or conflicting interests should be declared at the time that the correspondence is submitted. Correspondence should be submitted within one month of the distribution date for the Journal. Correspondence may not be accepted in certain circumstances e.g. if it is discourteous, inaccurate, potentially libellous, irrelevant, uninteresting or lacks cogency. Correspondence may be edited for length, grammatical correctness, and journal style. Authors of articles discussed in correspondence will be given the opportunity to respond. The correspondence, together with a declaration of any interests and any subsequent comment from the author, may be published in the Journal and/or on the website. Please submit your correspondence to the Correspondence Editor ([email protected]). READERSHIP FEEDBACK The comments of readers on each issue of the journal are welcomed. Please see the hyperlink provided elsewhere in the journal in the Readers' Feedback section to complete a short SurveyMonkey questionnaire. PUBLISHING YOUR WORK The JoMO aims to disseminate good practice about medicines optimisation to pharmacists, doctors, nurses and other healthcare professionals. The focus is on ‘optimisation’, which relates to quality and improving patient care, rather than cost aspects. The JoMO aims to follow the ‘Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals’ published by the International Committee of Medical Journal Editors (ICMJE) and known as ‘The Uniform Requirements’ and the Committee on Publication Ethics (COPE) ‘Code of Conduct’. Guidance for Authors is available at http://www.jmedopt.com. All material should be sent electronically to the Editor ([email protected]).